Steven C Marx

US Patent:

20050192256, Sep 1, 2005

Filed:

Dec 2, 2004

Appl. No.:

11/002014

Inventors:

Joel Melnick - Wilmette IL, US
Laura Williams - Gurnee IL, US
Michael Amdahl - Wauconda IL, US
Jin Tian - Waukegan IL, US
Steven Marx - Hoffman Estates IL, US
Coleen Hall - Glen Ellyn IL, US
Dheerendra Kommala - Gurnee IL, US

International Classification:

A61K031/59

US Classification:

514167000

Abstract:

The subject invention relates to methods of using Vitamin D compounds such as, for example, paricalcitol and calcitriol, in the treatment of patients undergoing hemodialysis. More specifically, administration of Vitamin D compounds appears to reduce the incidence of hospitalization, length of days spent in the hospital and morbidity in treated patients.

US Patent:

20060154902, Jul 13, 2006

Filed:

Aug 15, 2003

Appl. No.:

10/524376

Inventors:

Joel Melnick - Wilmette IL, US
Laura Williams - Gurnee IL, US
Michael Amdahl - Wauconda IL, US
Steven Marx - Hoffman Estates IL, US
Mark O'Brien - Libertyville IL, US
Angelo Mathes - Montreal, CA

International Classification:

A61K 31/59

US Classification:

514167000

Abstract:

Formulations containing a Vitamin D compound or analog, such as paricalcitol (Zemplar™) are useful for shortening hospital stays in chronic kidney disease patients with or without hyperparathyroidism. Also disclosed are methods of shortening hospital stays for chronic kidney disease patients with or without hyperparathyroidism, and methods for determining reduction length of hospital stay in chronic kidney disease patients with or without hyperparathyroidism. Titration to serum calcium or serum PTH is avoided by use of the invention.

US Patent:

20100010030, Jan 14, 2010

Filed:

Feb 4, 2009

Appl. No.:

12/365639

Inventors:

Rita I. Jain - Evanston IL, US
Andrea E. Best - Lake Forest IL, US
Earle Lockhart - Lake Bluff IL, US
Steven E. Marx - Hoffman Estates IL, US
James W. Thomas - Grayslake IL, US
Pamela Giang Vo - Gurnee IL, US

Assignee:

ABBOTT LABORATORIES - ABBOTT PARK IL

International Classification:

A61K 31/4355

US Classification:

514282

Abstract:

The present invention generally provides a method of treatment and improvement of quality of life for patients adversely affected by various pain conditions. One preferred embodiment provides a method of treatment of acute pain, moderate to moderately severe pain, chronic pain, non-cancer pain, osteoarthritic pain, bunionectomy pain or lower back pain in a patient in need thereof, comprising providing at least one or two dosage form having about 15 mg of hydrocodone and its salt and about 500 mg of acetaminophen, once, twice or thrice daily. Preferably, the dosage form is about 30 mg of hydrocodone and about 1000 mg of acetaminophen taken twice daily. Alternatively, the dosage form is about 15 mg of hydrocodone and about 500 mg of acetaminophen taken twice daily.

US Patent:

20160136154, May 19, 2016

Filed:

Nov 19, 2015

Appl. No.:

14/946643

Inventors:

- North Chicago IL, US
Andrea E. Best - Lake Forest IL, US
Earle Lockhart - Gurnee IL, US
Steven E. Marx - Hoffman Estates IL, US
James W. Thomas - Grayslake IL, US
Pamela Giang Vo - Gurnee IL, US

International Classification:

A61K 31/485
A61K 31/167

Abstract:

The present invention generally provides a method of treatment and improvement of quality of life for patients adversely affected by various pain conditions. One preferred embodiment provides a method of treatment of acute pain, moderate to moderately severe pain, chronic pain, non-cancer pain, osteoarthritic pain, bunionectomy pain or lower back pain in a patient in need thereof, comprising providing at least one or two dosage form having about 15 mg of hydrocodone and its salt and about 500 mg of acetaminophen, once, twice or thrice daily. Preferably, the dosage form is about 30 mg of hydrocodone and about 1000 mg of acetaminophen taken twice daily. Alternatively, the dosage form is about 15 mg of hydrocodone and about 500 mg of acetaminophen taken twice daily.